GLP-1 Eligibility: BMI, Health Conditions and Medical Criteria
Interest in GLP-1 receptor agonists has grown rapidly because of their effectiveness in supporting weight loss and improving metabolic health. Medications such as semaglutide injections and tirzepatide injections have changed the way obesity is treated, but they aren’t prescribed based on weight alone.
Doctors follow evidence-based clinical criteria to determine whether a weight loss medication is appropriate for each individual. In this article, we’ll explain who qualifies for GLP-1 weight loss treatment and the factors that influence eligibility.
What Is GLP-1 Weight Loss Treatment?
GLP-1 weight loss treatment uses a class of prescription medications called GLP-1 receptor agonists to help people with obesity or overweight lose weight and improve their metabolic health. These medications mimic glucagon-like peptide-1 (GLP-1), a hormone naturally released by the gut after eating. By reducing appetite, increasing feelings of fullness, slowing stomach emptying, and helping regulate blood sugar levels, they make it easier to eat less without constantly feeling hungry.
Today, several weight loss medications use this mechanism. Semaglutide injections, marketed under brands such as Wegovy, and Mounjaro injections (tirzepatide) are among the most commonly prescribed options. While these medications have transformed obesity care, they are not intended for everyone. Doctors recommend different GLP-1 treatments based on a person’s BMI, overall health, medical history, and weight loss goals.
Who Is Eligible for GLP-1 Weight Loss Treatment?
Not everyone looking to lose weight is automatically eligible for GLP-1 weight loss treatment. While these medications have transformed obesity care, they are prescription therapies designed for people who are most likely to benefit from them.
The World Health Organization recognizes obesity as a chronic, progressive disease that requires long-term management. In its first global guideline on GLP-1 therapies for obesity, WHO conditionally recommends these medications for appropriate adults as part of a comprehensive treatment plan that includes lifestyle and behavioral support.
When assessing your eligibility, doctors typically consider:
- Body Mass Index (BMI): BMI is often the starting point for determining eligibility, but it is only one part of the assessment.
- Weight-related health conditions: Certain medical conditions may influence whether the benefits of treatment outweigh the risks.
- Medical history: Your current medications, previous health conditions, and potential contraindications help determine whether treatment is safe.
- Previous weight loss efforts: Doctors may consider the approaches you’ve already tried and your response to lifestyle interventions.
- Long-term treatment goals: GLP-1 medications work best as part of a comprehensive medical weight management plan that includes nutrition, physical activity, and ongoing follow-up.
No single factor determines whether you qualify for GLP-1 weight loss treatment. Instead, healthcare providers evaluate your overall health, medical history, and individual goals to develop a personalized treatment plan.
Does Your BMI Make You Eligible for GLP-1?
Body Mass Index (BMI) is one of the first tools doctors use to assess eligibility for GLP-1 therapy. It helps estimate whether excess body weight may be increasing your risk of obesity-related health conditions. However, BMI is a screening tool, not a diagnosis.
BMI Criteria For Western Populations
The World Health Organization recommends GLP-1 therapies for adults with obesity as part of comprehensive long-term care. In the Western world, obesity is generally defined as a BMI of 30 kg/m² or higher, with pharmacotherapy often considered for people with a BMI of 27 kg/m² or higher if they have obesity-related health conditions.
BMI Criteria for Asians
For Asians, the thresholds are lower because South Asians tend to develop metabolic complications, such as type 2 diabetes and cardiovascular disease, at lower BMI levels than many other populations. The 2025 Endocrine Society of India guidelines recommend considering anti-obesity medications for adults with:
- BMI ≥27 kg/m², even without obesity-related comorbidities.
- BMI ≥25 kg/m² if one or more weight-related health conditions are present.
These lower cutoffs reflect the higher cardiometabolic risk seen in Asian Indians and support earlier intervention when appropriate.
BMI Is Only One Part of the Assessment
Although BMI plays an important role, it doesn’t automatically determine whether you’ll receive a GLP-1 receptor agonist. Your healthcare provider will also consider your medical history, weight-related health conditions, previous weight-loss efforts, and long-term treatment goals before recommending the most appropriate approach.
If your BMI doesn’t meet the usual eligibility criteria, it doesn’t necessarily mean treatment isn’t an option.
Can I Get GLP-1 If I Have Other Health Conditions?
Many people assume that GLP-1 therapies are prescribed based on BMI alone. However, doctors also consider whether you have obesity-related health conditions that increase your risk of long-term complications. In fact, under both Western and Indian clinical guidelines, the presence of these conditions may make you eligible for weight loss medication at a lower BMI threshold.
These health conditions don’t automatically qualify you for treatment, but they help healthcare providers determine whether the potential benefits of GLP-1 receptor agonists outweigh the risks.
Type 2 Diabetes
Excess weight is one of the major risk factors for type 2 diabetes. GLP-1 medications can support weight loss while also improving blood sugar control, making them an important treatment option for eligible individuals with obesity and diabetes.
Prediabetes
Prediabetes is a warning sign that blood sugar levels are higher than normal but not yet in the diabetic range. For people living with overweight or obesity, addressing excess weight early may help reduce the risk of progressing to type 2 diabetes.
Hypertension and Cardiovascular Risk
Obesity is closely linked to high blood pressure and an increased risk of heart disease. Losing weight can improve cardiovascular health, which is why hypertension is often considered during a medical weight-loss assessment.
Obstructive Sleep Apnea
Excess body weight is a major contributor to obstructive sleep apnea. Weight reduction may improve symptoms in many individuals, making this an important consideration when assessing eligibility.
Non-Alcoholic Fatty Liver Disease (NAFLD) (Now known as MASLD– Metabolic dysfunction-Associated Steatotic Liver Disease)
Fat accumulation in the liver is common among people with obesity and metabolic dysfunction. Improving body weight may help reduce liver fat and improve overall metabolic health.
Polycystic Ovary Syndrome (PCOS) (Now known as PMOS- Polyendocrine Metabolic Ovarian Syndrome)
For women with obesity and PCOS, weight loss may improve insulin resistance, menstrual regularity, and other metabolic complications. Healthcare providers consider the individual’s overall health profile before recommending treatment.
What Happens If You’re Eligible for GLP-1?
If you’re eligible for GLP-1 weight loss treatment, the next step isn’t simply starting medication. A successful medical weight loss plan combines medication with ongoing clinical support, nutrition, physical activity, and regular follow-up to help you achieve sustainable results.
Depending on your individual health profile, your treatment plan may include:
- A comprehensive health assessment and baseline measurements
- Nutrition and lifestyle recommendations
- A personalized medication plan, if appropriate
- Regular follow-up appointments to monitor progress
- Dose adjustments, if needed
- Ongoing support to help build long-term healthy habits
Weight loss injections work best when they’re part of a comprehensive weight management program rather than a standalone solution. Regular monitoring also helps maximize benefits while identifying and managing any side effects that may arise during treatment.
Your Next Step with EZWeight
Finding the right weight loss solution starts with understanding your individual health, not just your BMI. At EZWeight, every journey begins with a comprehensive medical assessment that evaluates your metabolic health, medical history, lifestyle, prior weight-loss efforts, and long-term goals.
Medical weight loss is never one-size-fits-all. While GLP-1 therapies have transformed obesity care, they may not be necessary or appropriate for everyone. Treatment recommendations are based on your individual needs, clinical profile, and evidence-based guidelines. If GLP-1 is the right option for you, it becomes part of a personalized care plan. If another medical weight loss therapy is more appropriate, that’s the path we’ll recommend.
Our multidisciplinary team combines medical expertise, nutrition, lifestyle coaching, and ongoing support to help you achieve sustainable weight loss.
What you can expect with the EZWeight Medical Weight Loss Program
- A comprehensive eligibility assessment based on your 65 health markers, health profile, and evidence-based clinical criteria.
- Personalized treatment recommendations tailored to your medical needs and weight loss goals by the best physicians in obesity and metabolic care.
- Access to the most appropriate medical weight loss therapies, including GLP-1 treatment when clinically indicated.
- Nutrition and lifestyle coaching to support sustainable, long-term results by expert obesity coaches.
- Regular follow-ups and progress monitoring to help your treatment plan evolve with your needs.
- Continuous clinical support throughout your weight management journey.
At EZWeight, our goal isn’t simply to prescribe medication. It’s to help you find the safest, most effective, and most sustainable approach to achieving better health.
Ready to take the next step? Book your assessment with EZWeight and discover a personalized approach to medical weight loss.
Conclusion
Choosing a GLP-1 therapy isn’t about finding the newest or most popular weight loss medication. It’s about finding the right treatment for your individual health needs. While BMI and weight-related health conditions provide important guidance, they are only part of a broader clinical picture.
If you’re considering medical weight loss, focus on understanding your options rather than determining your eligibility on your own. A comprehensive assessment can help identify the approach that’s most appropriate for your health, whether that includes GLP-1 therapy or another evidence-based treatment. The goal is to improve your long-term health with a personalized plan that’s safe, sustainable, and designed around you.
Frequently Asked Questions (FAQs)
- How do I get approved for GLP-1?
Approval for GLP-1 treatment is based on evidence-based clinical criteria, not a single factor. Eligibility is typically assessed using your BMI, weight-related health conditions, medical history, previous weight loss efforts, and overall health profile to determine whether the benefits of treatment outweigh the risks.
- Can you get GLP-1 if you’re not obese?
Yes, in some cases. While GLP-1 medications are commonly prescribed for people with obesity, individuals who are overweight and have obesity-related health conditions may also be eligible. Eligibility depends on a comprehensive medical assessment rather than weight alone.
- Who is the EZWeight Medical Weight Loss Program for?
The EZWeight Medical Weight Loss Program is designed for adults looking for a personalized, clinically guided approach to weight management who have not achieved meaningful results through lifestyle modifications alone. Whether you’re exploring GLP-1 therapy or other evidence-based medical weight loss options, the program is tailored to your individual health needs, goals, and long-term success.
- Which GLP-1 is right for me?
There isn’t a single GLP-1 medication that’s right for everyone. The most appropriate option depends on your health goals, medical history, existing conditions, treatment preferences, and overall clinical assessment.
- How does EZWeight determine GLP-1 eligibility?
EZWeight uses a comprehensive, evidence-based assessment that considers your BMI, metabolic health, weight-related conditions, medical history, lifestyle, and previous weight loss efforts. This helps determine whether GLP-1 therapy is appropriate or whether another medical weight loss approach may be a better fit.
- Why am I not a candidate for GLP-1?
You may not be a suitable candidate if the potential risks outweigh the benefits or if you don’t meet the clinical eligibility criteria. Factors such as your BMI, medical history, current health conditions, pregnancy, certain contraindications, or previous adverse reactions may influence treatment recommendations.
- Which GLP-1 is best for inflammation?
GLP-1 medications are not prescribed specifically to treat inflammation. However, by supporting weight loss and improving metabolic health, they may help reduce chronic inflammation associated with obesity. The most appropriate treatment depends on your individual health needs and clinical profile.
References
- GLP-1 receptor agonists for obesity: eligibility across 99 countries. Lancet Diabetes & Endocrinology. 105–08https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00356-0/fulltext
- A Guide for Deciding If GLP-1s Are Right for You. Healthline. https://www.healthline.com/health/type-2-diabetes/considering-glp1s
- Qualifying for GLP-1 Weight Loss: Who’s a Good Candidate? Hopkins MD. https://www.hopkinsmd.com/blog/qualifying-for-glp-1-weight-loss-whos-a-good-candidate
- WHO issues global guideline on the use of GLP-1 medicines in treating obesity. World Health Organization. https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity